US$ 27.31
surmount-1 trial tirzepatide weight loss nondiabetic for the Maintenance of Body Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Tirzepatide after intensive lifestyle intervention
Description
Acute Gallbladder Disease: Tirzepatide may cause gallbladder problems, including gallstones

References Willard FS, Douros JD, Gabe MB, et al
Location: Primarily found in pancreatic beta cells, but also in adipose tissue, bone, and the central nervous system
On the other hand, other studies have reported no association between the use of GLP-1 agonists and the risk of thyroid cancer 49,50

Users on tirzepatide sometimes maintain or even gain weight while losing inches, particularly if they are simultaneously building muscle through resistance training

Youre not eating enough protein: When it comes to calories, its not just about the number, but also the balance of nutrients you get from those calories
